Discover
XRTX
XORTX Therapeutics Inc.
2.19
1 x 2.18
1 x 2.30
bid
ask
+
0.06
2.68%
1 @ 04:00 PM
2.30 +0.11 (5.17%)
| Ytd | -22.17% | |
| 1y | -46.79% |
2.16
day range
2.25
1.73
52 week range
7.05
| Open | 2.19 | Prev Close | 2.13 | Low | 2.16 | High | 2.25 | Mkt Cap | 609.05K |
| Vol | 11.55K | Avg Vol | 21.17K | EPS | -1.35 | P/E | -1.62 | Forward P/E | -0.67 |
| Beta | -0.21 | Short Ratio | 0.02 | Inst. Own | 6.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.12 | 200-d Avg | 2.48 | 1yr Est | 12.17 |
| Income Statement | |||
| Operating Expenses | 823.30K | ||
| Research and Development Expense | 33.11K | ||
| Selling, General and Administrative Expense | 248.75K | ||
| Operating Income | -823.30K | ||
| Net Income | -808.47K | ||
| Net Income Common Stock | -808.47K | ||
| Net Income Common Stock (USD) | -585.85K | ||
| Consolidated Income | -808.47K | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.42 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -808.47K | ||
| Earning Before Interest & Taxes (USD) | -585.85K | ||
| Weighted Average Shares | 1.39M | ||
| Weighted Average Shares Diluted | 1.39M | ||
| Balance Sheet | |||
| Cash and Equivalents | 250.28K | ||
| Cash and Equivalents (USD) | 181.36K | ||
| Trade and Non-Trade Receivables | 64.63K | ||
| Current Assets | 744.42K | ||
| Property, Plant & Equipment Net | 14.68K | ||
| Total Assets | 2.14M | ||
| Debt Current | 15.06K | ||
| Total Debt | 15.06K | ||
| Current Liabilities | 860.99K | ||
| Total Liabilities | 860.99K | ||
| Accumulated Retained Earnings (Deficit) | -24.63M | ||
| Accumulated Other Comprehensive Income | -52.60K | ||
| Shareholders Equity | 1.28M | ||
| Shareholders Equity (USD) | 930.29K | ||
| Assets Non-Current | 1.40M | ||
| Total Debt (USD) | 10.91K | ||
| Goodwill and Intangible Assets | 185.70K | ||
| Trade and Non-Trade Payables | 844.93K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.85K | ||
| Net Cash Flow from Financing | -104.20K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -614.24K | ||
| Issuance (Repayment) of Debt Securities | -22.23K | ||
| Net Cash Flow from Investing | -7.91K | ||
| Net Cash Flow from Operations | -501.36K | ||
| Effect of Exchange Rate Changes on Cash | -763.00 | ||
| Share Based Compensation | 7.82K | ||